We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Cheerfy allows businesses to exceed the expectations of every customer by knowing who they are and what they want the second they walk in the door. By using WiFi, hotels for example can get notifcations when VIP members arrive so they can speed up the check in process. 
days to go: Expired investment: £207,430
Alter Vego (AV) aims to create an extensive range of plant-based, customisable supplements. The company asserts that its production process is sustainable. It starts by creating a vegan protein base blend from ingredients such as pea, hemp, quinoa and brown rice that is ethically sourced and produced. It then develops daily sachets that contain Omega 3, B12, D3, K1, digestive enzymes, and probiotics to complement the base blend. AV argues that the sachets provide 100% of a user's Recommended Dietary Allowance (RDA) over any pre-mixed bulk blend. It aspires to become a contender in the global nutrition sector worth $702 billion. AV will use the investment for manufacturing and marketing its products across the UK.

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £46,455
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £752,246
Graphene Composites (GC) is a nano-materials technology company engaged in creating strongest, lightest, and most resilient materials. Using graphene and aerogels, GC creates high-performance composite armours, aerospace and renewable energy products. GC Shield active shooter protection for schools has received strong support from politicians, police and school authorities in the US and signals noteworthy revenue and profit potential.
days to go: Expired investment: £497,020
Drop Bear Beer Co. is a specialist brewer of less than 0.5% craft beers. The company asserts that its products are vegan, gluten-free, and low in calories. It has brewed over 160,000 bottles to date. Drop Bear argues that the Global Non-Alcoholic Drinks market was valued at $18 billion in 2020. It aims to be a significant contender in the segment. The company's products are available in six global markets. Drop Bear has won awards ranging from a World Beer Award to a Great British Entrepreneur Award. The company will use the investment to expand its team and build a second dedicated alcohol-free brewery in the UK.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £325,000
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment. 
days to go: Expired investment: £200,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph